Article Versions Notes

Rovas A, Neumann JK, Drost CC, Vollenberg R, Thölking G, Fobker M, Witzenrath M, Kümpers P, AGAMOTTO Study Group, CAPNETZ Study Group. Analysis of Urinary Glycosaminoglycans to Predict Outcome in COVID-19 and Community-Acquired Pneumonia—A Proof-of-Concept Study. Journal of Clinical Medicine. 2023; 12(16):5269. https://doi.org/10.3390/jcm12165269

Rovas, Alexandros, Julia Katharina Neumann, Carolin Christina Drost, Richard Vollenberg, Gerold Thölking, Manfred Fobker, Martin Witzenrath, Philipp Kümpers, AGAMOTTO Study Group, and CAPNETZ Study Group. 2023. "Analysis of Urinary Glycosaminoglycans to Predict Outcome in COVID-19 and Community-Acquired Pneumonia—A Proof-of-Concept Study" Journal of Clinical Medicine 12, no. 16: 5269. https://doi.org/10.3390/jcm12165269

Rovas, A., Neumann, J. K., Drost, C. C., Vollenberg, R., Thölking, G., Fobker, M., Witzenrath, M., Kümpers, P., AGAMOTTO Study Group, & CAPNETZ Study Group. (2023). Analysis of Urinary Glycosaminoglycans to Predict Outcome in COVID-19 and Community-Acquired Pneumonia—A Proof-of-Concept Study. Journal of Clinical Medicine, 12(16), 5269. https://doi.org/10.3390/jcm12165269